![Charlotta Elisabet Gummeson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charlotta Elisabet Gummeson
Direttore/Membro del Consiglio presso Lumina Adhesives AB
Profilo
Charlotta Elisabet Gummeson is currently a Director at Lumina Adhesives AB.
She has previously worked as a Director at Arterion AB, Laccure AB, and Tridentify AB.
She has also worked as a Marketing Manager at GSK Plc and as a Country Manager at Astellas Pharma, Inc. From 2009 to 2015, she worked as an Investment Manager at Almi Invest Fond SI AB.
Posizioni attive di Charlotta Elisabet Gummeson
Società | Posizione | Inizio |
---|---|---|
Lumina Adhesives AB
![]() Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Charlotta Elisabet Gummeson
Società | Posizione | Fine |
---|---|---|
Almi Invest Fond SI AB
![]() Almi Invest Fond SI AB Investment ManagersFinance Almi Invest Fond SI AB (Almi Invest Fond SI) is a venture capital subsidiary of Almi Företagspartner Väst AB founded in 1979. The firm is headquartered in Vastra Gotaland, Sweden. | Analista di Private Equity | 01/12/2015 |
Tridentify AB
![]() Tridentify AB Electronic Equipment/InstrumentsElectronic Technology Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden. | Direttore/Membro del Consiglio | - |
GSK PLC | Vendite & Marketing | - |
ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Laccure AB
![]() Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GSK PLC | Health Technology |
ASTELLAS PHARMA INC. | Health Technology |
Aziende private | 5 |
---|---|
Almi Invest Fond SI AB
![]() Almi Invest Fond SI AB Investment ManagersFinance Almi Invest Fond SI AB (Almi Invest Fond SI) is a venture capital subsidiary of Almi Företagspartner Väst AB founded in 1979. The firm is headquartered in Vastra Gotaland, Sweden. | Finance |
Lumina Adhesives AB
![]() Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Process Industries |
Arterion AB
![]() Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
Laccure AB
![]() Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
Tridentify AB
![]() Tridentify AB Electronic Equipment/InstrumentsElectronic Technology Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden. | Electronic Technology |
- Borsa valori
- Insiders
- Charlotta Elisabet Gummeson